These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33490981)

  • 1. Quantitative
    Lau SF; Wu W; Seo H; Fu AKY; Ip NY
    STAR Protoc; 2021 Mar; 2(1):100265. PubMed ID: 33490981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune hyperreactivity of Aβ plaque-associated microglia in Alzheimer's disease.
    Yin Z; Raj D; Saiepour N; Van Dam D; Brouwer N; Holtman IR; Eggen BJL; Möller T; Tamm JA; Abdourahman A; Hol EM; Kamphuis W; Bayer TA; De Deyn PP; Boddeke E
    Neurobiol Aging; 2017 Jul; 55():115-122. PubMed ID: 28434692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
    J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology.
    Krabbe G; Halle A; Matyash V; Rinnenthal JL; Eom GD; Bernhardt U; Miller KR; Prokop S; Kettenmann H; Heppner FL
    PLoS One; 2013; 8(4):e60921. PubMed ID: 23577177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
    Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
    Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody against C-terminal Abeta selectively elevates plasma Abeta.
    Gray AJ; Sakaguchi G; Shiratori C; Becker AG; LaFrancois J; Aisen PS; Duff K; Matsuoka Y
    Neuroreport; 2007 Feb; 18(3):293-6. PubMed ID: 17314674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gossypetin ameliorates 5xFAD spatial learning and memory through enhanced phagocytosis against Aβ.
    Jo KW; Lee D; Cha DG; Oh E; Choi YH; Kim S; Park ES; Kim JK; Kim KT
    Alzheimers Res Ther; 2022 Oct; 14(1):158. PubMed ID: 36271414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in phagocytosis and potassium channel activity in microglia of 5xFAD mice indicate alterations in purinergic signaling in a mouse model of Alzheimer's disease.
    Wendt S; Maricos M; Vana N; Meyer N; Guneykaya D; Semtner M; Kettenmann H
    Neurobiol Aging; 2017 Oct; 58():41-53. PubMed ID: 28697378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A regional and cellular analysis of the early intracellular and extracellular accumulation of Aβ in the brain of 5XFAD mice.
    Daini E; Secco V; Liao W; Zoli M; Vilella A
    Neurosci Lett; 2021 May; 754():135869. PubMed ID: 33857550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice.
    Das P; Howard V; Loosbrock N; Dickson D; Murphy MP; Golde TE
    J Neurosci; 2003 Sep; 23(24):8532-8. PubMed ID: 13679422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Phagocytic Properties of CD45
    Rangaraju S; Raza SA; Li NX; Betarbet R; Dammer EB; Duong D; Lah JJ; Seyfried NT; Levey AI
    Front Immunol; 2018; 9():405. PubMed ID: 29552013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
    Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration.
    Wilcock DM; Munireddy SK; Rosenthal A; Ugen KE; Gordon MN; Morgan D
    Neurobiol Dis; 2004 Feb; 15(1):11-20. PubMed ID: 14751766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
    Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
    Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
    Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
    Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement and microglia mediate early synapse loss in Alzheimer mouse models.
    Hong S; Beja-Glasser VF; Nfonoyim BM; Frouin A; Li S; Ramakrishnan S; Merry KM; Shi Q; Rosenthal A; Barres BA; Lemere CA; Selkoe DJ; Stevens B
    Science; 2016 May; 352(6286):712-716. PubMed ID: 27033548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deglycosylated anti-amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration.
    Takata K; Hirata-Fukae C; Becker AG; Chishiro S; Gray AJ; Nishitomi K; Franz AH; Sakaguchi G; Kato A; Mattson MP; Laferla FM; Aisen PS; Kitamura Y; Matsuoka Y
    Eur J Neurosci; 2007 Nov; 26(9):2458-68. PubMed ID: 17970733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting Amyloid Beta Deposition Using Distinct Strains of the Neurotropic Parasite Toxoplasma gondii as a Novel Tool.
    Cabral CM; McGovern KE; MacDonald WR; Franco J; Koshy AA
    ASN Neuro; 2017; 9(4):1759091417724915. PubMed ID: 28817954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.